Objective: The aim of this study was to analyze in parallel the 6 th and the newest 7 th AJJCC/UICC (American Joint Committee on Cancer/ International Union Against Cancer) staging system in order to highlight changes brought by the new staging system. Methods: We analyzed data obtained retrospectively from 134 hospitalized patients diagnosed with gastric carcinomas, who underwent surgery at the Surgery Clinics of the County Emergency Clinical Hospital of Tîrgu Mureș, Romania between 2008-2010. The data have been obtained from histopathology reports, and the analyzed parameters were the following: age, gender and pTNM staging. For all cases included in the study restaging was performed according to the 7 th AJJCC/UICC staging system. Results: 71.66% of cases were adenocarcinomas, 7.46% mucinous adenocarcinoma, 14.17% signet ring cell carcinoma, and 6.71% undifferentiated carcinoma. The signet ring cell carcinomas predominated before 65 years of age (p = 0.003). Compared to the 6 th staging system, in the new system pT2 percentages decreased signifi cantly from 38.8% to 6.71%, and pT4 increases from 11.19% to 55.97% (p <0.0001). The pN3 cases increased from 20.9% to 45.52%, because all cases classifi ed as pN2 in the old staging system, became pN3 in the new system. Some of the pN1 cases turned into pN2 in the new system (p = 0.004). Stage IV cases also decreased from 29.85% to 14.94%, due to regrouping of stage III. Conclusions: There are signifi cant changes between the two staging systems. The new staging system aims to achieve a better postoperative follow-up.
Introduction
Gastric cancer is one of the most frequent gastrointestinal tumors, and represents the second cause of cancer death worldwide, although global incidence is declining [1] .
It is known that most of gastric cancer patients are diagnosed in advanced stages, due to unspecifi c symptoms, and also to late reporting of patients to the physician [2] . Surgery is the only option providing substantial improvement of survival in cases with early diagnosis, but even in patients diagnosed with early stages, the 5-year survival rate is about 50% [3] . Patients with advanced stages of gastric cancer can benefi t from palliative care or neoadjuvant chemotherapy. Th us, accurate quantifi cation of tumor stage is an extremely important aspect in establishing the subsequent treatment protocol for the patient.
Th e stage of the disease also represents one of the most important prognostic factors of gastric cancer; therefore TNM staging has the main role in establishing the treatment protocol [4] . In 2010 the 7 th TNM staging of gastric carcinomas has been introduced by the American Joint Committee on Cancer (AJCC) and International Union Against Cancer (UICC) [5] .
Th e present study aims to highlight the importance of changes brought by the 7 th TNM staging of AJCC/UICC, in order to achieve a better postoperative staging. Th e changes brought by the 7 th staging system compared to the 6 th staging system are listed in Table I [5, 6] .
Methods
One-hundred forty-three patients who underwent surgical intervention during 2008-2010 were enrolled in the study. Open surgery was performed in each case to remove the gastric tumor. In all cases, formalin-fi xed embedded tissues were used. Sections were dewaxed and were stained with Hematoxylin-Eosin.
We analyzed the histological type and grade of the tumor. Th ese parameters were correlated with the patients' age and gender. Only carcinomas of the stomach were included in our study. Lymphomas, carcinoid tumors and gastrointestinal stromal tumors were excluded.
We analyzed in parallel the 6 th and 7 th AJCC/UICC staging systems [5, 6] in order to underline the clinical signifi cance of the new staging of gastric carcinomas.
Data was collected with Microsoft Excel, and analyzed with GraphPad InStat software. Categorical data analysis was conducted with the chi-square test. Th e level of significance was set at p <0.05.
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Results

Clinico-pathological features
Analysis of the study group revealed that most of the cases were males (67.88%), and only 32.12% were females. Th e male/female ratio was about 2.11.
Mean age was 68 years for females (range 23-86 years), and 70 years for males (range 23-87 years).
Distribution of cases based of histological type was as follows: 5.96% well diff erentiated adenocarcinomas (G1), 25.37% moderately diff erentiated adenocarcinomas (G2), 40.33% poorly diff erentiated adenocarcinomas (G3), 7.46% mucinous adenocarcinomas, 14.17% signet ring cell carcinomas, and 6.71% undiff erentiated carcinomas. Th ere was no signifi cant correlation between the gender of the patients and histological type (p = 0.2008).
Th ere was a statistically signifi cant correlation between age and histological type of gastric carcinomas (p = 0.003).
We noted an increase in the frequency of moderately differentiated adenocarcinoma (21.64%) and poorly diff erentiated adenocarcinoma (26.9%) over 65 years of age. In case of younger patients signet ring cell carcinoma (8.95%) was more frequent (Figure 1 ).
Staging systems
Th e present study revealed a statistically signifi cant correlation between the depths of infi ltration of the primary tumor (pT) evaluated according to the 6 th AJCC/UICC staging system, and those evaluated with the 7 th AJCC/ UICC staging system (p <0.0001).
We noted that pT2 decreased signifi cantly from 38.8% to 6.71%, and pT4 increased from 11.19% to 55.97% (p <0.0001) (Figure 2 ).
Analyzing the number of invaded regional lymph nodes (pN) according to the two staging systems we also noted a statistically signifi cant correlation (p = 0.004).
We noted that pN3 increased signifi cantly from 20.9% to 45.52%, because all cases classifi ed as pN2 in the old Fig. 3 . Structure of the study group based on the number of lymph node metastases (pN) in both 6 th and 7 th AJCC/UICC staging system staging system became pN3 in the new system ( Figure 3) . A large number of pN1 cases from the old staging system turned into pN2 in the new system. Regarding the grouping stages, we observed an obvious decrease in the number of cases classifi ed as stage IV (29.85%) in the old staging system, compared to the new system (14.94%) (Figures 4 and 5) . Th is is due to the fact that most of the cases classifi ed as stage IV in the old staging system were reclassifi ed into stages IIIB, IIIC, IIIA in the new system. Likewise, cases classifi ed in the old system as stage IIIA were redistributed into stages IIB and IIIB in the new system.
Discussion
Th e TNM staging system takes into consideration the most basic parameters of cancer, and it determines the extent of the disease, providing guidance for treatment planning, and predicting outcome [7] .
Out of the total number of gastric cancer cases admitted to and investigated at the County Emergency Clinical Hospital of Tîrgu Mureş, Romania, 134 cases were included in the study, all being gastric carcinomas.
Preponderance of gastric tumors in males was obvious; in our study the male/female ratio was 2.11, in line with bibliographical data [1] .
We noted a predominance of adenocarcinomas (71.66%) over other carcinomas (28.34%) but there was no statistically signifi cant correlation between the gender of the patients and the histological type of the tumor.
G1 and G2 adenocarcinomas were more frequently after 65 years of age, and an increase in frequency of signet ring cell carcinoma in younger patients was observed. Th ese data correspond to those reported by other authors [1] .
Regarding the tumor staging, we should mention again that in the old system pT4 referred to tumor invasion into adjacent structures, while in the new staging system pT4 is subdivided into T4a (tumor invasion into serosa) and T4b (tumor invasion into adjacent structures) [5] . Practically, pT3 of the old system now corresponds to pT4a. Th us, cases classifi ed into pT3 (44.77%) are labeled as pT4 (55.97%) in the new system. Th is explains the large number of pT4 (55.97%) cases of the new staging system versus the small number of pT4 (11.19%) cases of the old system.
Similarly, the ratio of pT2 cases of the old system (38.8%) decreases signifi cantly to 6.71% in the new system. Th is is due to the following: in the old system pT2 referred to tumor invasion into the muscularis propria or subserosa, while in the new staging system pT2 represents only muscularis propria invasion, while subserosa invasion is classifi ed as pT3 [5, 6] . Th us, T2b of the old system becomes pT3, and pT2a turns into T2.
Th e most recent studies did not demonstrate signifi cant diff erences between survival of cases classifi ed as pT2 and pT3 in the new system [7] .
Some researchers reported that patients with stage IV gastric cancer as classifi ed by the 6 th edition system could be divided into two subgroups. Patients downstaged to stage III in the 7 th edition system had better prognosis than those who remained in stage IV. Even if these patients were divided into three substages (stage IIIB, IIIC, IV) they still had diff erent prognoses. Subdivision of stage IV gastric cancer into IVa and IVb may help predict the outcome of patients with stage IV gastric cancer as classifi ed by the 6 th edition system [7, 8] .
Details of pN classifi cation based on the number of metastatic lymph nodes were also changed. N1 of the old staging system has been divided into N1 and N2, while N2 and N3 are classifi ed as N3 in the new system [5] .
Our study analyzed the number of regional metastatic lymph nodes according to the two staging systems, and noted a statistically signifi cant correlation. All cases classifi ed as pN2 (24.62%) in the old staging system were reclassifi ed as pN3 (45.52%). pN1 (32.08%) cases became pN1 (16.41%) and pN2 (15.67%) in the new system. Many studies demonstrated that N stage of the 6 th edition system was not suitable for prognostic prediction in clinical analysis, because of the inappropriate cut-off s of that stage. In a study performed on 308 gastric cancer cases with therapeutic resection, classifi ed by the 6 th edition system, Deng et al. established that the most appropriate cutoff s of metastatic lymph nodes are 0, 1-4, 5-8, and 9 [9] . In several multicenter retrospective studies performed on 652 resected early gastric cancer cases classifi ed by the 6 th edition system, Roviello et survival rate in early gastric cancer patients was 92% for patients with negative nodes, 82% for patients with 1-3 positive nodes, 73% for 4-6 positive nodes, and 27% for 6 positive nodes [10] . In accordance with Deng et al. [9] N2 and N3 patients in their study using the 6 th edition system had similar survival [11] . Th e studies mentioned above demonstrated that in the 6 th AJCC/UICC edition N stage refl ected less accurately patient prognosis. According to the theory mentioned by Ueno et al., the criteria for evaluating the performance of the staging systems were as follows: (1) homogeneity within subgroups, (2) discriminatory ability between diff erent groups, and (3) monotonicity of gradients demonstrated in the association between stages and survival rates [12] . In the 6 th edition staging system, the survival rate of the six substages had signifi cant diff erences, while in the 7 th edition system, the discriminatory ability between the eight substages appeared more powerful. Th us, the 7 th edition UICC TNM staging system is superior to the 6 th edition system in terms of homogeneity, discriminatory, and monotonicity of gradients [7] .
Conclusion
Th e present study highlighted signifi cant diff erences between the two staging systems. Th e new system aims at a better tumor staging, and a better accuracy in evaluating prognosis and strategies for adjuvant therapy.
Th e pTNM grading system seems to remain the key element of the treatment protocol of gastric cancer patients.
